Pharmablock Sciences to redeem convertible bonds early

Nanjing PharmaBlock Sciences Co. Ltd. announced the early redemption of its convertible bonds, effective from September 18, 2025. The redemption price is set at CNY 100.62 per bond, which includes the par value and accrued interest at an annual rate of 1.5%. This decision was made after the company's stock price met the callable conditions, trading above 130% of the current conversion price for at least 15 out of 30 consecutive trading days between July 25, 2025, and August 14, 2025.

The last day for trading the convertible bonds is September 15, 2025, and the last day for conversion is September 17, 2025. Holders who do not convert by the deadline will have their bonds mandatorily redeemed at the CNY 100.62 price per bond. The current conversion price for the bonds is CNY 33.61 per share.

Investors are advised that the current secondary market price of Pharmablock Sciences' convertible bonds significantly exceeds the redemption price, making conversion into shares financially advantageous. Shareholders should ensure they have open Shenzhen Stock Exchange GEM trading permissions to facilitate conversion, as failure to convert by the deadline may result in a loss due to the lower redemption price.